HLA-DRA Antikörper
-
- Target Alle HLA-DRA Antikörper anzeigen
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser HLA-DRA Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), ELISA
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Antigen affinity purification
- Immunogen
- Synthetic peptide of human HLA-DRA
- Isotyp
- IgG
- Top Product
- Discover our top product HLA-DRA Primärantikörper
-
anti-HLA Class II DR alpha (HLA-DRA) (AA 26-254) antibody
HLA-DRA Reaktivität: Human WB, IHC, FACS, ELISA, ICC Wirt: Maus Monoclonal 1C11A5 unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 26-216) antibodyHLA-DRA Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 27-216) antibodyHLA-DRA Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 48-75), (N-Term) antibodyHLA-DRA Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB19526 unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 1-254) antibodyHLA-DRA Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) antibodyHLA-DRA Reaktivität: Human IHC, FACS, IF, StM Wirt: Maus Monoclonal 19-26-1-same as MB-26-1 unconjugated
anti-HLA Class II DR alpha (HLA-DRA) antibodyHLA-DRA Reaktivität: Human, Maus, Ratte WB, IHC, IF, ELISA, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) antibodyHLA-DRA Reaktivität: Human IHC Wirt: Kaninchen Monoclonal MSVA-470R unconjugated Recombinant Antibody
anti-HLA Class II DR alpha (HLA-DRA) (AA 26-221) antibodyHLA-DRA Reaktivität: Kaninchen WB, IHC, IP, ICC Wirt: Meerschweinchen Polyclonal unconjugated
anti-HLA Class II DR alpha (HLA-DRA) (AA 149-177), (C-Term) antibodyHLA-DRA Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB19527 unconjugated
-
- Applikationshinweise
- IHC 1:50-1:100, ELISA 1:5000-1:10000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.9 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
- Andere Bezeichnung
- HLA-DRA (HLA-DRA Produkte)
- Synonyme
- HLA-DRA1 antikoerper, MLRW antikoerper, DR-alpha antikoerper, HLA-DRA antikoerper, Mamu-DRA1 antikoerper, major histocompatibility complex, class II, DR alpha L homeolog antikoerper, major histocompatibility complex, class II, DR alpha antikoerper, hla-dra.L antikoerper, HLA-DRA antikoerper, MAMU-DRA antikoerper, BOLA-DRA antikoerper
- Hintergrund
- HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5.
- UniProt
- P01903
- Pathways
- T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events
-
